Furthermore, based on data reported in the Human Protein Atlas database, AP2A2, PLST, PLSI, BLVRB and SLC2A1 were associated with poor 5-year overall survival in pancreatic cancer (S2 Table). Here, AP2A2 is linked to pancreatic neoplasm.